Results 81 to 90 of about 100,760 (212)

Prognostic Effect of Sarcopenia and Nutritional Factors on Survival in Patients With Newly Diagnosed Multiple Myeloma: A Retrospective Exploratory Study

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 2, April 2026.
ABSTRACT Background Multiple myeloma (MM) is a hematological malignancy associated with poor prognosis. Prognostic prediction based on patient fitness may facilitate the optimization of therapeutic strategies. This study aimed to explore the prognostic significance of sarcopenia, the prognostic nutritional index (PNI) and the controlling nutritional ...
Xuxing Shen   +6 more
wiley   +1 more source

Radioresistant Extramedullary Plasmacytoma of the Maxillary Sinus: A Case Report and review article [PDF]

open access: yesIranian Journal of Otorhinolaryngology, 2015
Introduction: Plasmacytoma is a monoclonal proliferation of plasma cells. It can be an isolated lesion, for which the term extramedullary plasmacytoma is used, or a representation of multiple myeloma.The upper respiratory tract is the most common site ...
Matin Ghazizadeh   +2 more
doaj  

Treatment Discontinuation After Achieving MRD Negativity in Multiple Myeloma in the Pre‐BCMA Era: A Prospective, Single‐Centre Study

open access: yeseJHaem, Volume 7, Issue 2, April 2026.
ABSTRACT Objectives Minimal/measurable residual disease (MRD) negativity in multiple myeloma (MM) is associated with favourable outcomes; nonetheless, evidence supporting treatment discontinuation remains limited. We evaluated the feasibility of discontinuing antimyeloma therapy in patients with MRD negativity.
Kota Sato   +11 more
wiley   +1 more source

Cytological Findings of 140 Bile Samples from Dogs and Cats and Associated Clinical Pathological Data [PDF]

open access: yes, 2015
BACKGROUND: Cholecystocentesis can be part of the diagnostic workup of hepatobiliary disease in small animals, but literature on cytological evaluation of bile is scant.
Boomkens   +16 more
core   +2 more sources

Extramedullary Disease—Achilles Heel in Myeloma?

open access: yesAmerican Journal of Hematology, Volume 101, Issue 3, Page 521-536, March 2026.
ABSTRACT Despite advances in therapy, extramedullary disease (EMD) remains an aggressive form of multiple myeloma associated with poor outcomes. Patients with true EMD, in which plasmacytomas have become completely independent of bone, have a particularly poor prognosis. The pathogenesis of EMD is driven by complex mechanisms involving loss of adhesion
Shaji Kumar   +7 more
wiley   +1 more source

A case study of extramedullary plasmacytoma in a tertiary care centre

open access: yesMRIMS Journal of Health Sciences, 2017
Extramedullary plasmacytoma is a rare soft tissue neoplasm characterized by monoclonal proliferation of plasma cells. We report a case of extramedullary plasmacytoma in a 45 year old male patient with a history of nasal obstruction and a polypoid mass ...
P Sujatha, Kumuda
doaj   +1 more source

Radiation induced lichen planus - an uncommon side effect [PDF]

open access: yes, 2019
Cutaneous lichen planus is classically characterized by violaceous, pruritic, planar papules and plaques, most commonly affecting the extremities. Lichen planus following radiation therapy is extremely rare and lichen planus following radiation therapy ...
Chen, Yi-Chun   +4 more
core  

What Is Your Diagnosis? Submandibular Mass in a Dog

open access: yes
Veterinary Clinical Pathology, EarlyView.
Whitney K. Chandler   +3 more
wiley   +1 more source

Extramedullary Plasmacytoma in the Maxillary Sinus

open access: yesPhilippine Journal of Otolaryngology Head and Neck Surgery, 2009
Objective: To describe an intranasal mass initially diagnosed and treated as benign, that eventually turned out to be a malignant extramedullary plasmacytoma of the maxillary sinus, and to review the literature on its presenting signs and symptoms ...
Jennifer De Silva-Leonardo   +3 more
doaj   +1 more source

Estimating the prevalence of hematological malignancies and precursor conditions using data from Haematological Malignancy Research Network (HMRN) [PDF]

open access: yes, 2016
Objective: Well-established cancer registries that routinely link to death registrations can estimate prevalence directly by counting patients alive at a particular point in time (observed prevalence).
Crouch, Simon   +4 more
core   +1 more source

Home - About - Disclaimer - Privacy